Skip to content

Formulation and physicochemical evaluation of zolpidem sublingual film and comparative study of effect whit Zolpidem tablet in patient with chronic insomnia

Formulation and physicochemical evaluation of zolpidem sublingual film and comparative study of effect whit Zolpidem tablet in patient with chronic insomnia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180120038450N3
Enrollment
40
Registered
2022-01-15
Start date
2022-01-21
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia. Insomnia

Interventions

Intervention 1: Intervention group: In this study, zolpidem is used as a sublingual film with polyvinyl alcohol and beta cyclodextrin polymers. The film contains 5 mg of zolpidem sublingually. Each pa

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 64 Years

Inclusion criteria

Inclusion criteria: 20_64 years old Difficulty falling asleep, persistent sleep, or poor quality sleep No drug addiction in the last 12 months Do not smoke more than 10 cigarettes a day or equivalent amounts of cocaine Do not consume more than 40 grams of alcohol per day Do not consume more than 6 glasses of caffeinated beverages Not getting pregnant or breastfeeding or trying to conceive Do not take any medication or supplement that affects the patient's sleep or wakefulness for one week before the screening BMI 18_30

Exclusion criteria

Exclusion criteria: History of allergy to zolpidem Neurological and mental diseases Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Scores from the Pittsburgh and The Leeds Sleep Evaluation questionnaires. Timepoint: After taking the drug. Method of measurement: Score from answering the questionnaires.

Secondary

MeasureTime frame
Time to start sleeping. Timepoint: After taking the drug. Method of measurement: Answer the questionnaire questions.;Duration of sleep. Timepoint: After taking the drug. Method of measurement: Answer the questionnaire questions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadis Mansouri

Kermanshah University of Medical Sciences

Hadis.Mansouri74@gmail.com+98 31 3776 1327

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026